you are here:

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals

BSE Live

Nov 23, 16:00
479.80 -1.65 (-0.34%)
Volume
AVERAGE VOLUME
5-Day
104,073
10-Day
106,531
30-Day
121,620
147,463
  • Prev. Close

    481.45

  • Open Price

    481.45

  • Bid Price (Qty.)

    479.80 (250)

  • Offer Price (Qty.)

    479.80 (21)

NSE Live

Nov 23, 15:57
479.85 -2.00 (-0.42%)
Volume
AVERAGE VOLUME
5-Day
1,802,945
10-Day
2,181,938
30-Day
2,828,468
2,998,394
  • Prev. Close

    481.85

  • Open Price

    482.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    479.85 (693)

Financials

2019 2018 2017 2016 2015
Quarterly Results of Glenmark Pharma (in Rs. Cr.) Jun '20 Mar '20 Dec '19 Sep '19 Jun '19  
Net Sales/Income from operations 1,682.92 1,607.73 1,816.29 1,742.62 1,455.23  
Other Operating Income -- -- -- 47.20 43.56  
Total Income From Operations 1,682.92 1,607.73 1,816.29 1,789.82 1,498.79  
EXPENDITURE  
Consumption of Raw Materials 591.74 549.64 615.38 567.59 519.37  
Purchase of Traded Goods 76.27 83.61 92.14 92.87 96.61  
Increase/Decrease in Stocks -15.72 51.89 -13.52 19.69 -9.28  
Power & Fuel -- -- -- -- --  
Employees Cost 237.24 242.39 264.12 345.79 220.02  
depreciat 35.81 35.23 37.82 33.32 32.17  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 284.65 478.69 444.62 383.35 363.43  
P/L Before Other Inc. , Int., Excpt. Items & Tax 472.94 166.29 375.72 347.21 276.48  
Other Income 134.85 251.29 94.49 192.47 68.54  
P/L Before Int., Excpt. Items & Tax 607.78 417.57 470.21 539.67 345.02  
Interest 59.94 63.57 59.57 65.17 68.08  
P/L Before Exceptional Items & Tax 547.85 354.00 410.64 474.51 276.94  
Exceptional Items 27.99 18.55 -- -- --  
P/L Before Tax 575.84 372.55 410.64 474.51 276.94  
Tax 113.36 23.37 65.11 42.52 49.10  
P/L After Tax from Ordinary Activities 462.48 349.19 345.53 431.99 227.84  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 462.48 349.19 345.53 431.99 227.84  
Equity Share Capital 28.22 28.22 28.22 28.22 28.22  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 16.39 12.38 12.25 15.31 8.07  
Diluted EPS 16.39 12.38 12.25 15.31 8.07  
EPS After Extra Ordinary  
Basic EPS. 16.39 12.38 12.25 15.31 8.07  
Diluted EPS. 16.39 12.38 12.25 15.31 8.07  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited